Hikma Pharmaceutical reported 4.37B in Assets for its second fiscal semester of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Artemis Alpha ATS:LN 164.51M 22.2M
AstraZeneca AZN:LN 100273M 5090M
Bayer BAYN:GR € 125782M 5541M
Fresenius FRE:GR € 73114M 1152M
Fresenius Medical Care FMS:US $ 34724.13M 357.57M
Galapagos GLPG:NA € 5100.31M 92.84M
Genmab GEN:DC DK 24914M 287M
GlaxoSmithKline GSK:LN 89689M 10586M
GRIFOLS GRF:SM € 16213.05M 75.45M
H. Lundbeck A/S LUN:DC 35.07B 418M
Hikma Pharmaceutical HIK:LN 4.37B 192M
Lonza Group LONN:SW 16.46B 1.3B
Merck MRK:GR € 46235M 873M
Orion ORNBV:FH € 1224.7M 110.7M
Recordati REC:IM € 3642.95M 826.75M